Atlas Wealth’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$510K Buy
2,008
+22
+1% +$5.13K 0.07% 123
2026
Q1
$485K Hold
1,986
0.15% 80
2025
Q4
$411K Sell
1,986
-100
-5% -$19.8K 0.12% 77
2025
Q3
$387K Hold
2,086
0.12% 76
2025
Q2
$325K Hold
2,086
0.12% 81
2025
Q1
$346K Buy
2,086
+226
+12% +$35.4K 0.13% 73
2024
Q4
$269K Hold
1,860
0.1% 79
2024
Q3
$301K Sell
1,860
-1,860
-50% -$296K 0.13% 65
2024
Q2
$542K Buy
3,720
+1,860
+100% +$277K 0.06% 134
2024
Q1
$294K Hold
1,860
0.14% 63
2023
Q4
$290K Hold
1,860
0.16% 62
2023
Q3
$290K Sell
1,860
-758
-29% -$125K 0.05% 144
2023
Q2
$416K Hold
2,618
0.08% 125
2023
Q1
$406K Hold
2,618
0.08% 126
2022
Q4
$462K Buy
+2,618
New +$452K 0.12% 83

Other funds holding JNJ

Atlas Wealth's JNJ Position: Q2 2026 in Review

Atlas Wealth increased its Johnson & Johnson (JNJ) stake by 1.1% in Q2 2026, buying an estimated $5.13K and bringing the position to 2,008 shares worth $510K. The position accounts for 0.07% of the portfolio, ranked #123.

Atlas Wealth first reported a position in JNJ in Q4 2022 and has held it in 15 quarters since. The position peaked at $542K in Q2 2024. 4,656 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Atlas Wealth held 2,008 shares of Johnson & Johnson worth $510K as of Q2 2026.
  • Atlas Wealth bought 22 Johnson & Johnson shares in Q2 2026, an estimated $5.13K.
  • Johnson & Johnson made up 0.07% of Atlas Wealth's portfolio in Q2 2026, its #123 holding.
  • Atlas Wealth first reported a position in Johnson & Johnson in Q4 2022 and has held it in 15 quarters since.
  • Atlas Wealth's Johnson & Johnson position peaked at $542K in Q2 2024.
  • 4,656 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Atlas Wealth's 13F filing for Q2 2026, filed 28 Jul 2026.